Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belinostat in Platinum Resistant or LMP Ovarian Tumors
NCT00301756Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belinostat in ovarian epithelial cancer, primary peritoneal carcinoma (PPC), fallopian tube cancer (PFTC), borderline ovarian tumor (BOT), sponsored by National Cancer Institute. Started Sep 2006; status: completed.
02
Drugs
belinostat
03
Conditions
ovarian epithelial cancerprimary peritoneal carcinoma (PPC)fallopian tube cancer (PFTC)borderline ovarian tumor (BOT)
Beyond the preview
Go deeper on NCT00301756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301756.